Emerging molecular targets for treatment of erectile dysfunction: vascular and regenerative therapies on the horizon.

INTRODUCTION Erectile dysfunction (ED) has reached epidemic proportions not expected to abate because of population aging and chronic diseases that accompany advanced age. Vasculopathy is a main cause, but damage to penile innervation also underlies many cases of ED. Phosphodiesterase inhibitor therapies do not help all men with ED, making the search for… (More)